Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 4.9% ownership in Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share (GPCR) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.6% | 5,583,855 | 0 | 5,583,855 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.6% | 5,583,855 | 0 | 5,583,855 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.9% | 4,053,954 | 0 | 4,053,954 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.9% | 4,053,954 | 0 | 4,053,954 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 643,536 | 0 | 643,536 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 643,536 | 0 | 643,536 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4.5% | 9,637,809 | 0 | 9,637,809 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 4.9% | 10,437,066 | 0 | 10,437,066 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 4.9% | 10,437,066 | 0 | 10,437,066 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 4.9% | 10,437,066 | 0 | 10,437,066 | /s/ Mark N. Lampert | Mark N. Lampert |